Be in the know. 15 key reads for Tuesday…

  1. 10 stock picks from Jefferies for investors who want to be ‘trendy’ as the economy recovers (MarketWatch)
  2. Dividend Stocks With Solid Payout Prospects (Barrons)
  3. Here’s one ‘remarkable’ difference between COVID-19 and the 1918 Spanish flu (MarketWatch)
  4. Novavax shares soar 38% premarket on news of $1.6 billion in funding for COVID-19 vaccine candidate (MarketWatch)
  5. Regeneron’s stock gains on $450 million manufacturing deal with U.S. for experimental COVID-19 treatment (MarketWatch)
  6. Gilead Will Make a Profit on Remdesivir This Year, Says Analyst (Barron’s)
  7. Behind Oil’s Rise Is a Historic Drop in U.S. Crude Output (Wall Street Journal)
  8. Elon Musk’s red satin Tesla ‘short shorts’ sell out in minutes (New York Post)
  9. The Next Energy Battle: Renewables vs. Natural Gas (New York Times)
  10. Economists call for more direct cash payments tied to the health of the economy (Reuters)
  11. Disney+ Sees Massive Surge In Downloads During ‘Hamilton’ Weekend (Benzinga)
  12. Revisiting Coronavirus Vaccine Timelines: Moderna Denies Delay, Pfizer Advances Project Lightspeed And More (Benzinga)
  13. Peter Thiel’s Palantir Confidentially Files To Go Public (Benzinga)
  14. Warren Buffett’s Bet Is a Midstream Buying Signal (Wall Street Journal)
  15. Samsung says its second quarter profits likely rose 23% (CNBC)